View in EDS HTML Full Text PDF Full Text

Safety and effectiveness of disease-modifying therapies after switching from natalizumab.

Saved in:
Bibliographic Details
Title: Safety and effectiveness of disease-modifying therapies after switching from natalizumab.
Authors: Zeineddine M; Inserm U1094, IRD U270, Univ. Limoges, CHU Limoges, EpiMaCT-Epidemiology of chronic diseases in tropical zone, Institute of Epidemiology and Tropical Neurology, Omega Health, Limoges, France.; School of Pharmacy, Lebanese American University, Byblos, Lebanon., Al-Roughani R; Al-Amiri Hospital, Kuwait City, Kuwait., Farouk Ahmed S; Ibn Sina Hospital, Kuwait City, Kuwait., Khoury S; American University of Beirut Medical Center, Nehme and Therese Tohme Multiple Sclerosis Center, Beirut, Lebanon., El-Ayoubi N; American University of Beirut Medical Center, Nehme and Therese Tohme Multiple Sclerosis Center, Beirut, Lebanon., Al-Mahdawi A; Baghdad Medical City Teaching Hospital, Baghdad, Iraq., Al-Khabouri J; Department of Neurology, The Royal Hospital, Muscat, Oman., Al-Asmi A; Neurology Unit, Department of Medicine, College of Medicine and Health Sciences and Sultan Qaboos University Hospital, Sultan Qaboos University, Muscat, Oman., Chentouf A; Neurology Department, University Hospital Center, Oran, Algeria., Inshasi J; MS Department, Rashid Hospital and Dubai Medical College, Dubai Health Authority, Dubai, United Arab Emirates., Gouider R; Department of Neurology, LR18SP03, Clinical Investigation Center 'Neurosciences and Mental Health,' Razi University Hospital-Manouba, Tunis, Tunisia., Mrabet S; Department of Neurology, LR18SP03, Clinical Investigation Center 'Neurosciences and Mental Health,' Razi University Hospital-Manouba, Tunis, Tunisia., Shalaby N; Neurology Department, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt., Massouh J; Neurology Institute and MS Center, Harley Street Medical Center, Abu Dhabi, United Arab Emirates., Mohamed Ramzy Hasan Mohamed F; Neurology Institute and MS Center, Harley Street Medical Center, Abu Dhabi, United Arab Emirates., Al-Hajje A; Faculty of Pharmacy, Lebanese University, Beirut, Lebanon.; National Institute of Public Health, Clinical Epidemiology and Toxicology (INSPECT-LB), Beirut, Lebanon., Salameh P; Faculty of Pharmacy, Lebanese University, Beirut, Lebanon.; National Institute of Public Health, Clinical Epidemiology and Toxicology (INSPECT-LB), Beirut, Lebanon.; School of Medicine, Lebanese American University, Byblos, Lebanon; Department of Primary Care and Population Health, University of Nicosia Medical School, Nicosia, Cyprus., Dimassi H; Faculty of Pharmacy, Lebanese University, Beirut, Lebanon.; National Institute of Public Health, Clinical Epidemiology and Toxicology (INSPECT-LB), Beirut, Lebanon.; School of Medicine, Lebanese American University, Byblos, Lebanon; Department of Primary Care and Population Health, University of Nicosia Medical School, Nicosia, Cyprus., Boumediene F; Inserm U1094, IRD U270, Univ. Limoges, CHU Limoges, EpiMaCT-Epidemiology of chronic diseases in tropical zone, Institute of Epidemiology and Tropical Neurology, Omega Health, Limoges, France., Yamout B; Neurology Institute and MS Center, Harley Street Medical Center, Abu Dhabi, United Arab Emirates.
Source: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2024 Jul; Vol. 30 (8), pp. 1026-1035. Date of Electronic Publication: 2024 Jul 26.
Publication Type: Journal Article; Observational Study; Multicenter Study
Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39054846
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety and effectiveness of disease-modifying therapies after switching from natalizumab.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zeineddine+M%22">Zeineddine M</searchLink>; Inserm U1094, IRD U270, Univ. Limoges, CHU Limoges, EpiMaCT-Epidemiology of chronic diseases in tropical zone, Institute of Epidemiology and Tropical Neurology, Omega Health, Limoges, France.; School of Pharmacy, Lebanese American University, Byblos, Lebanon.<br /><searchLink fieldCode="AU" term="%22Al-Roughani+R%22">Al-Roughani R</searchLink>; Al-Amiri Hospital, Kuwait City, Kuwait.<br /><searchLink fieldCode="AU" term="%22Farouk+Ahmed+S%22">Farouk Ahmed S</searchLink>; Ibn Sina Hospital, Kuwait City, Kuwait.<br /><searchLink fieldCode="AU" term="%22Khoury+S%22">Khoury S</searchLink>; American University of Beirut Medical Center, Nehme and Therese Tohme Multiple Sclerosis Center, Beirut, Lebanon.<br /><searchLink fieldCode="AU" term="%22El-Ayoubi+N%22">El-Ayoubi N</searchLink>; American University of Beirut Medical Center, Nehme and Therese Tohme Multiple Sclerosis Center, Beirut, Lebanon.<br /><searchLink fieldCode="AU" term="%22Al-Mahdawi+A%22">Al-Mahdawi A</searchLink>; Baghdad Medical City Teaching Hospital, Baghdad, Iraq.<br /><searchLink fieldCode="AU" term="%22Al-Khabouri+J%22">Al-Khabouri J</searchLink>; Department of Neurology, The Royal Hospital, Muscat, Oman.<br /><searchLink fieldCode="AU" term="%22Al-Asmi+A%22">Al-Asmi A</searchLink>; Neurology Unit, Department of Medicine, College of Medicine and Health Sciences and Sultan Qaboos University Hospital, Sultan Qaboos University, Muscat, Oman.<br /><searchLink fieldCode="AU" term="%22Chentouf+A%22">Chentouf A</searchLink>; Neurology Department, University Hospital Center, Oran, Algeria.<br /><searchLink fieldCode="AU" term="%22Inshasi+J%22">Inshasi J</searchLink>; MS Department, Rashid Hospital and Dubai Medical College, Dubai Health Authority, Dubai, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22Gouider+R%22">Gouider R</searchLink>; Department of Neurology, LR18SP03, Clinical Investigation Center 'Neurosciences and Mental Health,' Razi University Hospital-Manouba, Tunis, Tunisia.<br /><searchLink fieldCode="AU" term="%22Mrabet+S%22">Mrabet S</searchLink>; Department of Neurology, LR18SP03, Clinical Investigation Center 'Neurosciences and Mental Health,' Razi University Hospital-Manouba, Tunis, Tunisia.<br /><searchLink fieldCode="AU" term="%22Shalaby+N%22">Shalaby N</searchLink>; Neurology Department, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt.<br /><searchLink fieldCode="AU" term="%22Massouh+J%22">Massouh J</searchLink>; Neurology Institute and MS Center, Harley Street Medical Center, Abu Dhabi, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22Mohamed+Ramzy+Hasan+Mohamed+F%22">Mohamed Ramzy Hasan Mohamed F</searchLink>; Neurology Institute and MS Center, Harley Street Medical Center, Abu Dhabi, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22Al-Hajje+A%22">Al-Hajje A</searchLink>; Faculty of Pharmacy, Lebanese University, Beirut, Lebanon.; National Institute of Public Health, Clinical Epidemiology and Toxicology (INSPECT-LB), Beirut, Lebanon.<br /><searchLink fieldCode="AU" term="%22Salameh+P%22">Salameh P</searchLink>; Faculty of Pharmacy, Lebanese University, Beirut, Lebanon.; National Institute of Public Health, Clinical Epidemiology and Toxicology (INSPECT-LB), Beirut, Lebanon.; School of Medicine, Lebanese American University, Byblos, Lebanon; Department of Primary Care and Population Health, University of Nicosia Medical School, Nicosia, Cyprus.<br /><searchLink fieldCode="AU" term="%22Dimassi+H%22">Dimassi H</searchLink>; Faculty of Pharmacy, Lebanese University, Beirut, Lebanon.; National Institute of Public Health, Clinical Epidemiology and Toxicology (INSPECT-LB), Beirut, Lebanon.; School of Medicine, Lebanese American University, Byblos, Lebanon; Department of Primary Care and Population Health, University of Nicosia Medical School, Nicosia, Cyprus.<br /><searchLink fieldCode="AU" term="%22Boumediene+F%22">Boumediene F</searchLink>; Inserm U1094, IRD U270, Univ. Limoges, CHU Limoges, EpiMaCT-Epidemiology of chronic diseases in tropical zone, Institute of Epidemiology and Tropical Neurology, Omega Health, Limoges, France.<br /><searchLink fieldCode="AU" term="%22Yamout+B%22">Yamout B</searchLink>; Neurology Institute and MS Center, Harley Street Medical Center, Abu Dhabi, United Arab Emirates.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229509185%22">Multiple sclerosis (Houndmills, Basingstoke, England)</searchLink> [Mult Scler] 2024 Jul; Vol. 30 (8), pp. 1026-1035. <i>Date of Electronic Publication: </i>2024 Jul 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Observational Study; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22SAGE+Publications%22">SAGE Publications </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9509185 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1477-0970 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213524585%22">13524585 </searchLink><i>NLM ISO Abbreviation: </i>Mult Scler <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39054846
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/13524585241261565
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1026
    Titles:
      – TitleFull: Safety and effectiveness of disease-modifying therapies after switching from natalizumab.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zeineddine M
      – PersonEntity:
          Name:
            NameFull: Al-Roughani R
      – PersonEntity:
          Name:
            NameFull: Farouk Ahmed S
      – PersonEntity:
          Name:
            NameFull: Khoury S
      – PersonEntity:
          Name:
            NameFull: El-Ayoubi N
      – PersonEntity:
          Name:
            NameFull: Al-Mahdawi A
      – PersonEntity:
          Name:
            NameFull: Al-Khabouri J
      – PersonEntity:
          Name:
            NameFull: Al-Asmi A
      – PersonEntity:
          Name:
            NameFull: Chentouf A
      – PersonEntity:
          Name:
            NameFull: Inshasi J
      – PersonEntity:
          Name:
            NameFull: Gouider R
      – PersonEntity:
          Name:
            NameFull: Mrabet S
      – PersonEntity:
          Name:
            NameFull: Shalaby N
      – PersonEntity:
          Name:
            NameFull: Massouh J
      – PersonEntity:
          Name:
            NameFull: Mohamed Ramzy Hasan Mohamed F
      – PersonEntity:
          Name:
            NameFull: Al-Hajje A
      – PersonEntity:
          Name:
            NameFull: Salameh P
      – PersonEntity:
          Name:
            NameFull: Dimassi H
      – PersonEntity:
          Name:
            NameFull: Boumediene F
      – PersonEntity:
          Name:
            NameFull: Yamout B
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2024 Jul
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1477-0970
          Numbering:
            – Type: volume
              Value: 30
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Multiple sclerosis (Houndmills, Basingstoke, England)
              Type: main
ResultId 1